Business Description
Renerve Ltd
ISIN : AU0000358616
Description
Renerve Ltd specializes in developing a range of ready-to-use products that are cleaner, safer and better for repairing or replacing damaged peripheral nerves, resulting in better patient outcomes. Its product candidates include NervAlign Bionic Nerve, NervAlign Nerve Graft, and NervAlign Nerve Cuff.
Financial Strength
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 340.55 | |||||
| Equity-to-Asset | 0.94 | |||||
| Debt-to-EBITDA | -0.01 | |||||
| Piotroski F-Score | N/A/9 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History |
|---|
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 72.12 | |||||
| 9-Day RSI | 59.32 | |||||
| 14-Day RSI | 51.52 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 16.29 | |||||
| Quick Ratio | 15.92 | |||||
| Cash Ratio | 15.61 | |||||
| Days Sales Outstanding | 123.73 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History |
|---|
Profitability Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Operating Margin % | -1760.45 | |||||
| Net Margin % | -1686.44 | |||||
| FCF Margin % | -1298.31 | |||||
| ROE % | -40.23 | |||||
| ROA % | -37.68 | |||||
| ROIC % | -754.48 | |||||
| ROC (Joel Greenblatt) % | -5390 | |||||
| ROCE % | -36.21 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PS Ratio | 180 | |||||
| PB Ratio | 3.46 | |||||
| Price-to-Tangible-Book | 3.6 | |||||
| EV-to-EBIT | -6.7 | |||||
| EV-to-EBITDA | -7.1 | |||||
| EV-to-Revenue | 102.04 | |||||
| EV-to-FCF | -7.86 | |||||
| Price-to-Net-Current-Asset-Value | 3.6 | |||||
| Price-to-Net-Cash | 3.6 | |||||
| Earnings Yield (Greenblatt) % | -14.93 | |||||
| FCF Yield % | -9 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Renerve Ltd Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil A$) | 0.177 | ||
| EPS (TTM) (A$) | -0.021 | ||
| Beta | 0 | ||
| Volatility % | 0 | ||
| 14-Day RSI | 51.52 | ||
| 14-Day ATR (A$) | 0.014457 | ||
| 20-Day SMA (A$) | 0.16475 | ||
| 12-1 Month Momentum % | 0 | ||
| 52-Week Range (A$) | 0.13 - 0.195 | ||
| Shares Outstanding (Mil) | 141.84 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 9999 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Renerve Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Renerve Ltd Stock Events
| Event | Date | Price(A$) | ||
|---|---|---|---|---|
| No Event Data | ||||
Renerve Ltd Frequently Asked Questions
What is Renerve Ltd(ASX:RNV)'s stock price today?
The current price of ASX:RNV is A$0.18. The 52 week high of ASX:RNV is A$0.20 and 52 week low is A$0.13.
When is next earnings date of Renerve Ltd(ASX:RNV)?
The next earnings date of Renerve Ltd(ASX:RNV) is .
Does Renerve Ltd(ASX:RNV) pay dividends? If so, how much?
Renerve Ltd(ASX:RNV) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers